Cargando…

In vivo analysis of Nef’s role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss

BACKGROUND: Nef is a multifunctional HIV-1 protein critical for progression to AIDS. Humans infected with nef(−) HIV-1 have greatly delayed or no disease consequences. We have contrasted nef(−) and nef(+) infection of BLT humanized mice to better characterize Nef’s pathogenic effects. RESULTS: Mice...

Descripción completa

Detalles Bibliográficos
Autores principales: Watkins, Richard L, Foster, John L, Garcia, J Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501112/
https://www.ncbi.nlm.nih.gov/pubmed/26169178
http://dx.doi.org/10.1186/s12977-015-0187-z
_version_ 1782381012967227392
author Watkins, Richard L
Foster, John L
Garcia, J Victor
author_facet Watkins, Richard L
Foster, John L
Garcia, J Victor
author_sort Watkins, Richard L
collection PubMed
description BACKGROUND: Nef is a multifunctional HIV-1 protein critical for progression to AIDS. Humans infected with nef(−) HIV-1 have greatly delayed or no disease consequences. We have contrasted nef(−) and nef(+) infection of BLT humanized mice to better characterize Nef’s pathogenic effects. RESULTS: Mice were inoculated with CCR5-tropic HIV-1(JRCSF) (JRCSF) or JRCSF with an irreversibly inactivated nef (JRCSFNefdd). In peripheral blood (PB), JRCSF exhibited high levels of viral RNA (peak viral loads of 4.71 × 10(6) ± 1.23 × 10(6) copies/ml) and a progressive, 75% loss of CD4(+) T cells over 17 weeks. Similar losses were observed in CD4(+) T cells from bone marrow, spleen, lymph node, lung and liver but thymocytes were not significantly decreased. JRCSFNefdd also had high peak viral loads (2.31 × 10(6) ± 1.67 × 10(6)) but induced no loss of PB CD4(+) T cells. In organs, JRCSFNefdd produced small, but significant, reductions in CD4(+) T cell levels and did not affect the level of thymocytes. Uninfected mice have low levels of HLA-DR(+)CD38(+)CD8(+) T cells in blood (1–2%). Six weeks post inoculation, JRCSF infection resulted in significantly elevated levels of activated CD8(+) T cells (6.37 ± 1.07%). T cell activation coincided with PB CD4(+) T cell loss which suggests a common Nef-dependent mechanism. At 12 weeks, in JRCSF infected animals PB T cell activation sharply increased to 19.7 ± 2.9% then subsided to 5.4 ± 1.4% at 14 weeks. HLA-DR(+)CD38(+)CD8(+) T cell levels in JRCSFNefdd infected mice did not rise above 1–2% despite sustained high levels of viremia. Interestingly, we also noted that in mice engrafted with human tissue expressing a putative protective HLA-B allele (B42:01), JRCSFNefdd exhibited a substantial (200-fold) reduced viral load compared to JRCSF. CONCLUSIONS: Nef expression was necessary for both systemic T cell activation and substantial CD4(+) T cell loss from blood and tissues. JRCSFNefdd infection did not activate CD8(+) T cells or reduce the level of CD4(+) T cells in blood but did result in a small Nef-independent decrease in CD4(+) T cells in organs. These observations strongly support the conclusion that viral pathogenicity is mostly driven by Nef. We also observed for the first time substantial host-specific suppression of HIV-1 replication in a small animal infection model. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-015-0187-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4501112
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45011122015-07-15 In vivo analysis of Nef’s role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss Watkins, Richard L Foster, John L Garcia, J Victor Retrovirology Research BACKGROUND: Nef is a multifunctional HIV-1 protein critical for progression to AIDS. Humans infected with nef(−) HIV-1 have greatly delayed or no disease consequences. We have contrasted nef(−) and nef(+) infection of BLT humanized mice to better characterize Nef’s pathogenic effects. RESULTS: Mice were inoculated with CCR5-tropic HIV-1(JRCSF) (JRCSF) or JRCSF with an irreversibly inactivated nef (JRCSFNefdd). In peripheral blood (PB), JRCSF exhibited high levels of viral RNA (peak viral loads of 4.71 × 10(6) ± 1.23 × 10(6) copies/ml) and a progressive, 75% loss of CD4(+) T cells over 17 weeks. Similar losses were observed in CD4(+) T cells from bone marrow, spleen, lymph node, lung and liver but thymocytes were not significantly decreased. JRCSFNefdd also had high peak viral loads (2.31 × 10(6) ± 1.67 × 10(6)) but induced no loss of PB CD4(+) T cells. In organs, JRCSFNefdd produced small, but significant, reductions in CD4(+) T cell levels and did not affect the level of thymocytes. Uninfected mice have low levels of HLA-DR(+)CD38(+)CD8(+) T cells in blood (1–2%). Six weeks post inoculation, JRCSF infection resulted in significantly elevated levels of activated CD8(+) T cells (6.37 ± 1.07%). T cell activation coincided with PB CD4(+) T cell loss which suggests a common Nef-dependent mechanism. At 12 weeks, in JRCSF infected animals PB T cell activation sharply increased to 19.7 ± 2.9% then subsided to 5.4 ± 1.4% at 14 weeks. HLA-DR(+)CD38(+)CD8(+) T cell levels in JRCSFNefdd infected mice did not rise above 1–2% despite sustained high levels of viremia. Interestingly, we also noted that in mice engrafted with human tissue expressing a putative protective HLA-B allele (B42:01), JRCSFNefdd exhibited a substantial (200-fold) reduced viral load compared to JRCSF. CONCLUSIONS: Nef expression was necessary for both systemic T cell activation and substantial CD4(+) T cell loss from blood and tissues. JRCSFNefdd infection did not activate CD8(+) T cells or reduce the level of CD4(+) T cells in blood but did result in a small Nef-independent decrease in CD4(+) T cells in organs. These observations strongly support the conclusion that viral pathogenicity is mostly driven by Nef. We also observed for the first time substantial host-specific suppression of HIV-1 replication in a small animal infection model. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-015-0187-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-14 /pmc/articles/PMC4501112/ /pubmed/26169178 http://dx.doi.org/10.1186/s12977-015-0187-z Text en © Watkins et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Watkins, Richard L
Foster, John L
Garcia, J Victor
In vivo analysis of Nef’s role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss
title In vivo analysis of Nef’s role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss
title_full In vivo analysis of Nef’s role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss
title_fullStr In vivo analysis of Nef’s role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss
title_full_unstemmed In vivo analysis of Nef’s role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss
title_short In vivo analysis of Nef’s role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss
title_sort in vivo analysis of nef’s role in hiv-1 replication, systemic t cell activation and cd4(+) t cell loss
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501112/
https://www.ncbi.nlm.nih.gov/pubmed/26169178
http://dx.doi.org/10.1186/s12977-015-0187-z
work_keys_str_mv AT watkinsrichardl invivoanalysisofnefsroleinhiv1replicationsystemictcellactivationandcd4tcellloss
AT fosterjohnl invivoanalysisofnefsroleinhiv1replicationsystemictcellactivationandcd4tcellloss
AT garciajvictor invivoanalysisofnefsroleinhiv1replicationsystemictcellactivationandcd4tcellloss